HKSTP Showcases Top Biotech Innovations and Attracts Global Enterprises at US BIO 2024
16 top-tier Park companies present their cutting-edge research, products and services, including a debut of InnoHK's Centre for Chinese Herbal Medicine Drug Development in the international arena
- Led by HKSTP, 16 top-tier park companies showcase top biotech innovations and attract global partners and fundings at US BIO 2024.
- HKSTP has unveiled a dynamic 1,000-square-foot Pavilion to display groundbreaking products and services and facilitate over 80 One-on-One partnering meetings.
- Our presence at BIO 2024 will further support their commercialisation efforts by facilitating direct interactions with global investors and funding bodies."
- Albert Wong, CEO of HKSTP said, "We are thrilled to once again demonstrate Hong Kong's enormous strength and potential in biotechnology at BIO 2024.